Genericplus Pharmacy Private Limited - Due diligence report

A 360° intelligence report on Genericplus Pharmacy Private Limited: trust score, financial health, credit view, compliance, directors, growt…

2019-11-16 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
GP Genericplus Pharmacy Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Genericplus Pharmacy Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
75/100
Trust Score
Low Risk

Genericplus Pharmacy Private Limited is assessed as Low Risk with a Trust Score of 75/100. Genericplus Pharmacy Private Limited is an active private limited indian non-government company incorporated in 2019, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Genericplus Pharmacy Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
75/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
60/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 60/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 3 court forum(s).
  • Delayed payments to MSME suppliers disclosed (169 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
MANJUSHA SANTOSH SHEDGE 01234567 Director 01/04/2018 6 yrs Approved
GIRISH KISHANLAL JAIN 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 3 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 80
Growth signals & trust indicators
Steady revenue growth: +1.42 over 2 year(s).
Operating for 6 years.
Active GST registration(s).
Distress signals & risk flags
3 director exits within 2 years.
MSME payment delays disclosed - latest outstanding 7.06 cr.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence70/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment68/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view71/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 9 events
06 Jan 2025
Director appointed
MANJUSHA SANTOSH SHEDGE (Director)
Director ceased
Kamlesh Kantilal Jain
Director ceased
Ashok Ganeshmalji Jain
30 Sep 2024
Last AGM held
Annual general meeting
29 Sep 2024
Director ceased
PIYUSH KISHANLAL JAIN
31 Mar 2024
Latest balance sheet
Filed with ROC
18 Apr 2023
Director ceased
SANTOSH MANSING SHEDGE
16 Nov 2019
Incorporated
Registered with Roc Mumbai I
Director appointed
GIRISH KISHANLAL JAIN (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 2 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sanj Fabrics Private Limited U74120DL2007PTC164992 Delhi, Delhi, India
Studio19 Offices Private Limited U51393KA2015PTC084085 Bangalore North, Karnataka, India
Sai Baba Oils & Chem Private Limited U15311MP2011PTC025737 Gwalior, Madhya Pradesh, India
Trifid Stores Private Limited U01100MP2019PTC049090 Indore, Madhya Pradesh, India
Mile Run India Private Limited U74999DL2020PTC371746 Delhi, Delhi, India
Shubhuja Commercial Private Limited U25200KA2021PTC152498 Bangalore, Karnataka, India
Anant Business Pvt Ltd. U51909WB1993PTC059742 Kolkata, West Bengal, India
Star Premier Paper Mart Private Limited U51909TN2005PTC055903 Chennai 600 001, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Genericplus Pharmacy Private Limited before audits and certifications: compliance score 60/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Genericplus Pharmacy Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 60/100, margin trends, ownership structure and peer set for Genericplus Pharmacy Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Genericplus Pharmacy Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Genericplus Pharmacy Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Genericplus Pharmacy Private Limited an active company?

Genericplus Pharmacy Private Limited has MCA status “Active” with a compliance score of 60/100 (Moderate).

Is Genericplus Pharmacy Private Limited financially healthy?

Genericplus Pharmacy Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Genericplus Pharmacy Private Limited?

Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Genericplus Pharmacy Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Genericplus Pharmacy Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Genericplus Pharmacy Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 60/100 (Moderate).

Is it risky to lend to Genericplus Pharmacy Private Limited?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.